The global veterinary biomarkers market size is expected to reach USD 2.14 billion in 2030 and is expected to grow at a CAGR of 12.90% from 2025 to 2030. The key drivers for the market growth are the increasing prevalence of numerous acute and chronic disorders among animals coupled with the growing demand for better & accurate diagnostic and monitoring technologies. According to the American Veterinary Medical Association, almost half of the dog population is developing cancer at the same rate as humans. This supports the requirement for biomarker-based specific diagnostic kits for timely disease predictions and treatments.
The COVID-19 pandemic created barriers and challenges in the global animal health industry that include decreased marketing & sales activities, low veterinary clinic admission, cancellation of routine pet check-ups, and a low number of disease diagnostic tests performed in veterinary hospitals. However, governments and veterinary organizations of various countries implemented strategies and safety measures to resume veterinary practices and research during the pandemic. According to the American Veterinary Medical Association, telemedicine services were widely incorporated in veterinary clinics and hospitals to curb the impact of lockdowns. Furthermore, the pet parents were given digital training to use certain diagnostic kits.
The increasing animal care expenditure in both developing and developed economies is a significant opportunity for market growth. According to the American Kennel Club (AKC), pet owners in the U.S. were spending more money on their pet’s wellness and related healthcare products. The American Pet Products Association reported that the overall pet industry sale exceeded USD 140 billion by the end of 2022. In addition, the research and development activity in the upcoming fields, such as biomarkers in the veterinary, has been significantly growing over the last decade. These factors are expected to boost the growth of the market.
Request a free sample copy or view report summary: Veterinary Biomarkers Market Report
The companion animals segment dominated the industry with the highest revenue share in 2024
The biomarkers, kits & reagents segment held the largest market share in 2024. This is owing to the wide availability of major brands of biomarkers and test kits launched by key players in the market
The disease diagnostics segment held the largest market share in 2024
The inflammatory & infectious diseases segment held the largest market share of 39.34% in 2024
North America veterinary biomarkers market held a 41.28% share in 2024
Grand View Research has segmented the global veterinary biomarkers market report based on animal type, product, application, disease type and region:
Veterinary Biomarkers Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
Companion Animals
Dogs
Cats
Others
Production Animals
Cows
Pigs
Others
Veterinary Biomarkers Product Type Outlook (Revenue, USD Million, 2018 - 2030)
Biomarkers, Kits & Reagents
Biomarker Readers
Veterinary Biomarkers Application Outlook (Revenue, USD Million, 2018 - 2030)
Disease Diagnostics
Preclinical Research
Others
Veterinary Biomarkers Disease Type Outlook (Revenue, USD Million, 2018 - 2030)
Inflammatory & Infectious Diseases
Cardiovascular Diseases
Skeletal Muscle Diseases
Tumor
Others
Veterinary Biomarkers Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Sweden
Denmark
Norway
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
Thailand
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
MEA
South Africa
Saudi Arabia
UAE
Kuwait
Rest of MEA
List of Key Players in Veterinary Biomarkers Market
Zoetis
Virbac
Life Diagnostics
ACUVET BIOTECH
Merck & Co., Inc.
IDEXX Laboratories, Inc.
MI:RNA Diagnostics Ltd.
Mercodia AB
Antech Diagnostics, Inc.
Avacta Animal Health Limited
"The quality of research they have done for us has been excellent..."